HALO
Halozyme Therapeutics, Inc.stockNASDAQ
At CloseNov 13, 2026 3:59:59 PM EST
100.30USD-0.368%(-0.37)2,276,201
After-hoursNov 13, 2026 4:02:30 PM EST
99.99USD-0.312%(-0.31)
HALO News
Halozyme downgraded at Morgan Stanley on valuation ·
Seeking Alpha
Halozyme director Matthew Posard sells $2.05M in HALO shares ·
Investing.com
3 Reasons Argenx Could Be a Top Biotech Stock for the Next Decade ·
The Motley Fool+1 source
Halozyme dips as Leerink downgrades on “marginal” Q3 upside ·
Seeking Alpha
